Abstract
Understanding the interactions of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) with humans is deeply grounded in immunology, from the diagnosis to pathogenesis, from the clinical presentations to the epidemiology, prevention, and treatment. However, the difficulty of capturing the complex and changeable array of immunological concepts and incorporating them into the strategies of control of the SARS-CoV-2 pandemic poses significant hindrances to establish optimal public health policies. The contribution of immunology to the control of the pandemic is to shed light on the features and mechanisms of the protective immunity elicited by SARS-CoV-2 infection and vaccines. Do they induce effective protective immunity? How? For how long? What is the effect of vaccination on individuals who were previously infected? To appropriately answer these questions, it is necessary to get rid of the outdated notion of a naïve, static, and closed immune system, which leads to misconceptions about susceptibility, specificity, immunological memory, and protective immunity. The present essay discusses these issues based on current immunological concepts.
Highlights
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has spread throughout the world at an astonishing rate, leading to overall sanitary, social, and economic disruption, and above all, causing an enormous burden of suffering and lost lives
Do they induce effective protective immunity? How? For how long? What is the effect of vaccination on individuals who were previously infected? To appropriately answer these questions, it is necessary to get rid of the outdated notion of a naïv e, static, and closed immune system, which leads to misconceptions about susceptibility, specificity, immunological memory, and protective immunity
A key yet unsettled aspect of the protective immunity to SARS-CoV-2 infection is the role of crossreactive T cells, found in 40% to 60% [64] to 100% [128, 129] of the unexposed healthy individuals and that react to different virus proteins as S, membrane (M) [65, 118], and nucleocapsid (N) proteins [62]
Summary
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has spread throughout the world at an astonishing rate, leading to overall sanitary, social, and economic disruption, and above all, causing an enormous burden of suffering and lost lives. The contribution of immunology to the control of the pandemic is to shed light on the features and mechanisms of the protective immunity elicited by SARS-CoV-2 infection and vaccines. This essay discusses the features of protective immunity induced by SARS-CoV-2 infection and vaccination based on the current immunological concepts.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
